Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia

PHASE3CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Vulvar Intraepithelial Neoplasia
Interventions
DRUG

Imiquimod

PROCEDURE

Surgery

Trial Locations (9)

1090

Department of General Gynecology and Gynecology Oncology, Medical University of Vienna, Vienna

4010

Dep. of Gynecology, Krankenhaus Barmherzige Schwestern Linz, Linz

4020

Dep. of Gynecology and Obstetrics, Landes Frauen- und Kinderklinik Linz, Linz

5020

Dep. of Gynecology and Obstetrics, Landeskrankenhaus Salzburg, Salzburg

6020

Department of Gynecology and Obstetrics, Medical University of Innsbruck, Innsbruck

8020

Dep. of Gynecology, Krankenhaus Barmherzige Brüder Graz, Graz

8036

Department of Obstetrics and Gynecology/ Medical University of Graz, Graz

Unknown

Dep. of Gynecology and Obstetrics, Klinikum Klagenfurt, Klagenfurt

Dep. of Gynecology and Obstetrics, Leoben

All Listed Sponsors
collaborator

Austrian Science Fund (FWF)

OTHER

lead

Medical University of Graz

OTHER

NCT01861535 - Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia | Biotech Hunter | Biotech Hunter